Research Scotland logo
View Item 
  •   Research Scotland Home
  • Biomathematics and Statistics Scotland (BioSS)
  • Journals
  • View Item
  •   Research Scotland Home
  • Biomathematics and Statistics Scotland (BioSS)
  • Journals
  • View Item
  •   Research Scotland Home
  • Biomathematics and Statistics Scotland (BioSS)
  • Journals
  • View Item
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy

Thumbnail
Date
26/03/2019
Author
Scally, C.
Abbas, H.
Ahearn, TS.
Srivanasan, J.
Rudd, A.
Mezincescu, AM.
Spath, N.
Yucel-Finn, A.
Yuecel, R.
Dospinescu, C.
Horgan, G.W.
Broadhurst, P.
Henning, A.
Newby, DE.
Semple, S.
Wilson, HM.
Dawson, D.
Version
2017-10-06
2017-10-06
Metadata
Show full item record
Abstract
Background: Acute stress induced (takotsubo) cardiomyopathy can result in a heart failure phenotype with a prognosis comparable to myocardial infarction. In this study, we hypothesized that inflammation is central to the pathophysiology and natural history of takotsubo cardiomyopathy. Methods: In a multi-centre study, we prospectively recruited 55 patients with takotsubo cardiomyopathy and 51 age, sex and co-morbidity matched control subjects. During the index event and at 5 months follow-up, patients with takotsubo cardiomyopathy underwent multiparametric cardiac magnetic resonance imaging including ultrasmall superparamagnetic particles of iron oxide (USPIO) enhancement for detection of inflammatory macrophages in the myocardium. Blood monocyte subpopulations and serum cytokines were assessed as measures of systemic inflammation. Matched controls underwent investigation at a single time point. Results: Subjects were predominantly middle aged (64±14years) women (90%). When compared to control subjects, patients with takotsubo cardiomyopathy had greater USPIO enhancement (expressed as the difference between pre-USPIO and post-USPIO T2*) in both ballooning (14.3±0.6 versus 10.5±0.9 ms, p<0.001) and non-ballooning (12.9±0.6 versus 10.5±0.9 ms, p=0.02) left ventricular myocardial segments. Serum interleukin-6 (23.1±4.5 versus 6.5±5.8 pg/mL, p< 0.001) and chemokine (C-X-C motif) ligand 1 (1903±168 versus 1272±177 pg/mL, p=0.01) concentrations, and classical CD14++CD16- monocytes (90±0.5 versus 87±0.9%, p=0.01) were also increased whilst intermediate CD14++CD16+ (5.4±0.3 versus 6.9±0.6%, p=0.01) and non-classical CD14+CD16++ (2.7±0.3% versus 4.2±0.5%, p=0.006) monocytes were reduced in patients with takotsubo cardiomyopathy. At 5 months, USPIO enhancement was no longer detectable in the left ventricular myocardium although there remained persistent elevations in serum interleukin-6 concentrations (p=0.009) and reductions in intermediate CD14++CD16+ monocytes (5.6±0.4 versus 6.9±0.6%, p=0.01). Conclusions: We demonstrate for the first time that takotsubo cardiomyopathy is characterized by a myocardial macrophage inflammatory infiltrate, changes in the distribution of monocyte subsets and an increase in systemic pro-inflammatory cytokines. Many of these changes persisted for at least 5 months suggesting a low-grade chronic inflammatory state. Clinical Trial Registration: URL: https://clinicaltrials.gov Unique identifier: NCT02897739 Key Words:
DOI
https://doi.org/10.1161/circulationaha.118.037975
Link
https://hdl.handle.net/20.500.12594/10099
Citation
Circulation, 139 (13), 1581-1592
Collections
  • Journals [121]
©Research Scotland Consortium
c/o RGBE 20a Inverleith Row
EH3 5LR
Edinburgh, Scotland, UK

Tel: 0131 248 2850
Email: info@ResearchScotland.ac.uk
Items in Research Scotland are protected by copyright with all rights reserved unless otherwise indicated.
  • Privacy & Cookies
  • Takedown Policy
  • Accessibility
  • Policies
  • Contact
Privacy &amp; Cookies
Takedown Policy
Accessibility
Policies
Contact
 
Advanced Search

Browse

All of Research ScotlandPartners & CollectionsBy Issue DateAuthorsTitlesSubjectsPublishersThis CollectionBy Issue DateAuthorsTitlesSubjectsPublishers

My Account

LoginRegister
©Research Scotland Consortium
c/o RGBE 20a Inverleith Row
EH3 5LR
Edinburgh, Scotland, UK

Tel: 0131 248 2850
Email: info@ResearchScotland.ac.uk
Items in Research Scotland are protected by copyright with all rights reserved unless otherwise indicated.
  • Privacy & Cookies
  • Takedown Policy
  • Accessibility
  • Policies
  • Contact
Privacy &amp; Cookies
Takedown Policy
Accessibility
Policies
Contact